Please login to the form below
iEnvision
This page shows the latest iEnvision news and features for those working in and with pharma, biotech and healthcare.
Otsuka utilises Envision Pharma Group’s medical affairs platform
The programme offers Otsuka’s stakeholders a more “user friendly” experience. In a bid to step up its medical affairs-related activity, Otsuka has introduced iEnvision - a programme by Envision Pharma ... Along with investigator sponsored studies,
Latest news
-
NCCN bolsters its Oncology Research Programme
Uses iEnvision to manage the programme’s projects. As a way to better support and manage multiple research projects, The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of ... Known as iEnvision, the programme was developed by
NCCN bolsters its Oncology Research Programme
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
90TEN promotes Claire Long and Sabrina Gomersall to lead Communications division
Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility.
-
Envision Pharma Group acquires doDOC to enable seamless document collaboration as part of iEnvision, its global medical affairs platform
While customers will have the choice to deploy doDOC standalone, the solution will be seamlessly integrated with Envision’s leading medical affairs platform, iEnvision. ... Envision is a leading provider of evidence-based communication services and
-
Envision Pharma Group appoints Manish Goel as Global Head of Envision Technology Solutions
At Envision, he will focus on the continuing transformation of iEnvision – the global medical affairs platform, solidifying its position as the leading Software as a Service (SaaS) platform and driving the ... Envision is a leading provider of
-
Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering
Since being founded in 2001, Envision has delivered strong year-on-year organic growth and established leadership in medical affairs strategy, medical communications, and enterprise-wide iEnvision technology. ... Envision is a leading provider of evidence
-
GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth
Its flagship technology iEnvision – a global medical affairs platform, supports medical strategy, scientific communications internal/external research, and grant/request management activities to help pharmaceutical companies operate their
90TEN promotes Claire Long and Sabrina Gomersall to lead Communications division
Envision Pharma Group acquires doDOC to enable seamless document collaboration as part of iEnvision, its global medical affairs platform
Envision Pharma Group appoints Manish Goel as Global Head of Envision Technology Solutions
Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering
GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth
More from PMHub
Approximately 4 fully matching, plus 7 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Events Executive
-
Depending on Experience
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Understanding the ‘real world’ starts and ends with the patient
- Onyx Health Launch Creative Studio After Record Year
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Tonix Pharmaceuticals to develop TNX-102 for long COVID syndrome
- Migraine-friendly colours for the home
PMHub
SEVEN STONES
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
